2m 2m 2m 2m 2m 2m 2m
ADC Therapeutic N (ADCT)
NYSE
$1.61+$0.10 (+6.36%)
Price as of Nov 11, 2026 7:42 PM EST- $213.2MMarket Cap
- -61.96%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
ADC Therapeutic N (ADCT)
$1.61+$0.10 (+6.36%)
ADCT | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.51 | ||
Change | -$0.16 (-9.58%) | ||
Open | $1.62 | ||
High | $1.73 | ||
Low | $1.48 | ||
Previous Close | $1.67 | ||
Volume | 1,310,688 | ||
30-Day Average Volume | 1,415,361 | ||
1-Week Change | -2.58% | ||
1-Month Change | -12.72% | ||
1-Year Change | -61.96% | ||
3-Year Change | 221.28% | ||
5-Year Change | -94.71% | ||
Fundamentals | |||
Shares Outstanding | 141.2M | ||
Total Assets | $255.9M | ||
Market Cap | $213.2M | ||
Enterprise Value | $140.1M | ||
Period: QTR TTM FY | |||
Revenue | $21.7M | ||
Net Income | -$25.3M | ||
Free Cash Flow | -$27.9M | ||
EBIT | -$20.8M | ||
EBITDA | -$20.8M | ||
Net Working Capital | $160.5M | ||
EPS | -$0.16 | ||
Enterprise Value/EBITDA | -7 | ||
Enterprise Value/Revenue | 6 | ||
P/B | -1 | ||
P/E | -9 | ||
PEG | 0 | ||
Price/Free Cash Flow | -8 | ||
Price/Operating Cash Flow | -8 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 7 | ||
Last Split Date | 05/10/2005 | ||
Earnings & Revenue